Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial
Crossref DOI link: https://doi.org/10.1007/s13555-016-0161-2
Published Online: 2016-12-19
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stockfleth, Eggert
von Kiedrowski, Ralph
Dominicus, Rolf
Ryan, John
Ellery, Adam
Falqués, Meritxell
Ivanoff, Nathalie
Azeredo, Rosario Rodriguez
Funding for this research was provided by:
Almirall S.A.